[Neurogenic control of venous hypertension in cardiac insufficiency].
D006333:Heart Failure / Q000209:etiology*; D006584:Hexamethonium Compounds / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D006584:Hexamethonium Compounds; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents
CONGESTIVE HEART FAILURE/etiology and pathogenesis; HEXAMETHONIUM COMPOUNDS/therapeutic use; HYPERTENSION/etiology and pathogenesis; VASOMOTOR DRUGS/therapeutic use
Control neurógeno de la hipertensión venosa de la insuficiencia cardíaca.